Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations.

Matsukuma E, Gotoh Y, Kuroyanagi Y, Yamada T, Iwasa M, Yamakawa S, Nagai T, Takagi N, Mae H, Iijima K, Bresin E.

Clin Exp Nephrol. 2011 Apr;15(2):269-74. doi: 10.1007/s10157-010-0375-z. Epub 2011 Jan 27.

PMID:
21271273
2.

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.

Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2005 Feb;16(2):555-63. Epub 2004 Dec 8.

3.

Molecular genetic analysis of Korean patients with coagulation factor XII deficiency.

Kwon MJ, Kim HJ, Lee KO, Jung CW, Kim SH.

Blood Coagul Fibrinolysis. 2010 Jun;21(4):308-12. doi: 10.1097/MBC.0b013e32833449df.

PMID:
20386432
4.

Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate.

Cho HY, Lee BS, Moon KC, Ha IS, Cheong HI, Choi Y.

Pediatr Nephrol. 2007 Jun;22(6):874-80. Epub 2007 Feb 13.

PMID:
17295030
5.

A case of atypical hemolytic uremic syndrome with a transient decrease in complement factor H.

Hahn H, Um EY, Park YS, Cheong HI.

Pediatr Nephrol. 2006 Feb;21(2):295-8. Epub 2005 Dec 17.

PMID:
16362720
6.

Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.

Dragon-Durey MA, Blanc C, Garnier A, Hofer J, Sethi SK, Zimmerhackl LB.

Semin Thromb Hemost. 2010 Sep;36(6):633-40. doi: 10.1055/s-0030-1262885. Epub 2010 Sep 23. Review.

PMID:
20865640
7.

The autoimmune disease DEAP-hemolytic uremic syndrome.

Skerka C, Zipfel PF, Müller D, Micklisch S, Riedl M, Zimmerhackl LB, Hofer J.

Semin Thromb Hemost. 2010 Sep;36(6):625-32. doi: 10.1055/s-0030-1262884. Epub 2010 Sep 23.

PMID:
20865639
8.

Novel deleterious mutation in the F12 gene in a Korean family with severe coagulation factor XII deficiency.

Kim HJ, Kim HJ, Kwon EH, Lee KO, Park IA, Kim SH.

Blood Coagul Fibrinolysis. 2010 Oct;21(7):683-6. doi: 10.1097/MBC.0b013e32833e429c.

PMID:
20729721
9.

Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.

Boyer O, Balzamo E, Charbit M, Biebuyck-Gougé N, Salomon R, Dragon-Durey MA, Frémeaux-Bacchi V, Niaudet P.

Am J Kidney Dis. 2010 May;55(5):923-7. doi: 10.1053/j.ajkd.2009.12.026. Epub 2010 Mar 3.

PMID:
20202729
10.

Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.

Józsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, Oppermann M, Skerka C, Zipfel PF.

Blood. 2007 Sep 1;110(5):1516-8. Epub 2007 May 10.

11.

[Incomplete hemolytic uremic syndrome associated with partial factor H deficiency].

Olaciregui Echenique I, Areses Trapote R, Ubetagoyena Arrieta M, Sota Busselo I, García Pardos C, Echaniz Aizpuru P.

An Pediatr (Barc). 2007 Feb;66(2):188-90. Spanish.

12.

[Hemolytic uremic syndrome in adults].

Hertig A, Ridel C, Rondeau E.

Nephrol Ther. 2010 Jul;6(4):258-71. doi: 10.1016/j.nephro.2010.03.002. Epub 2010 Apr 15. French.

PMID:
20399168
13.

Diarrhea-related hemolytic uremic syndrome: unmasking antifactor H antibodies.

Gupta A, Khaira A, Rathi OP, Mahajan S, Bhowmik D, Agarwal SK, Tiwari SC.

Saudi J Kidney Dis Transpl. 2011 Sep;22(5):1017-8.

14.

Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome.

Le Quintrec M, Zuber J, Noel LH, Thervet E, Frémeaux-Bacchi V, Niaudet P, Fridman WH, Legendre C, Dragon-Durey MA.

Am J Transplant. 2009 May;9(5):1223-9. doi: 10.1111/j.1600-6143.2009.02586.x. Erratum in: Am J Transplant. 2009 Sep;9(9):2205. Niauif, P [added]. Am J Transplant.2009 Nov;9(11):2647. Niauif, P [corrected to Niaudet, P].

15.

Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.

Dragon-Durey MA, Frémeaux-Bacchi V.

Springer Semin Immunopathol. 2005 Nov;27(3):359-74. Epub 2005 Nov 11. Review.

PMID:
16189652
16.

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

Licht C, Weyersberg A, Heinen S, Stapenhorst L, Devenge J, Beck B, Waldherr R, Kirschfink M, Zipfel PF, Hoppe B.

Am J Kidney Dis. 2005 Feb;45(2):415-21.

PMID:
15685522
17.

DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome.

Zipfel PF, Mache C, Müller D, Licht C, Wigger M, Skerka C; European DEAP-HUS Study Group.

Pediatr Nephrol. 2010 Oct;25(10):2009-19. doi: 10.1007/s00467-010-1446-9. Epub 2010 Feb 16. Review.

PMID:
20157737
18.

Plasmatherapy in atypical hemolytic uremic syndrome.

Loirat C, Garnier A, Sellier-Leclerc AL, Kwon T.

Semin Thromb Hemost. 2010 Sep;36(6):673-81. doi: 10.1055/s-0030-1262890. Epub 2010 Sep 23. Review.

PMID:
20865645
19.

Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.

Abarrategui-Garrido C, Martínez-Barricarte R, López-Trascasa M, de Córdoba SR, Sánchez-Corral P.

Blood. 2009 Nov 5;114(19):4261-71. doi: 10.1182/blood-2009-05-223834. Epub 2009 Sep 10.

20.

Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.

Abarrategui-Garrido C, Melgosa M, Peña-Carrión A, de Jorge EG, de Córdoba SR, López-Trascasa M, Sánchez-Corral P.

Am J Kidney Dis. 2008 Jul;52(1):171-80. doi: 10.1053/j.ajkd.2008.01.026. Epub 2008 Apr 18.

PMID:
18423815

Supplemental Content

Support Center